Injection TB500/thymosin beta 4 Peptide for bodybuilding to growth muscle

Peptides TB500
Other Name:Thymosin β4
Purity:99% HPLC
Packing:2mg/vial and 5mg/vial;10vials/box
Min Order:  1box
Payment:Bitcoin,Moneygram and Wester Union
Lead time:24hours after received payment
Safe shipping to US and most of Europe country
Storage:Shading, confined preservation,2-8°C

Product link to :www.astersteroids.com/injection-tb500-thymosin-beta-4-peptide-for-bodybuilding-to-growth-muscle-safe-shipping-with-good-price/
Product Name:TB500
Other Name:Thymosin β4
Sequence: AC-Ser-Asp-Lys-PRO-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-PRO-Leu-PRO-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser-OH
CAS No.: 77591-33-4/107761-42-2
MF:C212H350N56O78S
MW:4963.49
Purity:above 98%
Packing:2mg/vial and 5mg/vial;10vials/box
Appearance:White Lyophilized Powder
Method of Analysis: HPLC
Storage: Lyophilized peptides although stable at room temperature for 3 months, should be stored desiccated below -18° C. Upon reconstitution of the peptide it should be stored at 4° C between 2-21 days and for future use below -18° C. 

TB 500 Benefit:promote healing

TB-500 is a synthetic fraction of the protein thymosin beta-4 peptide, which is present in virtually all human and animal cells. The main purpose of this peptide is to promote healing. It also promotes creation of new blood and muscle cells. TB 500 Benefit have been observed in tendons, ligaments, muscle, skin, heart, and the eyes. Thymosin beta-4 is naturally produced in higher concentration where tissue has been damaged. This peptide is also a very potent anti-inflamatory agent. 
TB 500 Benefit  is an injectable peptide drug which can be used to promote healing, enhance range of motion in cases of injury, or reduce pain in case of injury by reducing inflammation.

What is Thymosin Beta-4 peptide?

Thymosin Beta-4 peptide is a protein which consists of 43 amino acids and is encoded by the gene TMSB4X in the human body. It has been studies in numerous clinical trials. Research has shown that if the thymosin beta-4 peptide is used after a heart attack it can reactivate cardiac progenitor cells to repair damaged heart tissue.